Perfusion Bioreactor Oxygen Sensing for Toxicity Monitoring

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for detecting toxicity in prescription drugs and cosmetics are costly and provide limited toxicokinetic information, relying on large numbers of cells and animal models that are inaccurate for predicting human toxicity, and lack real-time monitoring capabilities for long-term safety evaluations.

Innovation Solution

A perfusion bioreactor system with micro-wells and oxygen sensing particles for non-invasive, real-time monitoring of oxygen uptake in human cells, maintaining a three-dimensional microenvironment for up to two months, allowing continuous monitoring of cellular toxicity and mitochondrial respiration.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If current toxicity detection methods are used, then toxicity can be detected, but the cost increases dramatically and real-time monitoring is not achieved

Engineering Contradiction:
Improvetoxicity detection accuracyVSAvoidassay complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The invention extracts the essential measurement function (oxygen consumption detection) from complex multi-parameter assays. By using a single oxygen-sensitive fluorescent probe that directly reports mitochondrial function through oxygen consumption, the system eliminates the need for multiple end-point assays (MTT, JC1 staining, etc.) while maintaining toxicity detection accuracy.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention replaces mechanical/invasive measurement methods (Clark-type electrodes that consume oxygen during measurement, physical insertion of sensors) with optical detection of fluorescent probes. This substitution enables non-invasive, real-time monitoring without disturbing the cellular environment or consuming the measured oxygen.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Duration of action of moving object

If animal models are used for toxicity testing, then long-term safety can be evaluated, but accuracy for predicting human toxicity decreases

Engineering Contradiction:
Improvetesting durationVSAvoidtoxicity prediction accuracy
Core Design Contradiction:
Duration of action of moving objectVSMeasurement precision

Solution Approach 1:

The invention creates a simplified in vitro copy of the in vivo physiological environment using microfluidic devices that replicate blood flow, oxygen delivery, and metabolic conditions. This copying approach allows human cells to be maintained in culture for extended periods (over 28 days) with physiological relevance, eliminating the need for animal models while maintaining predictive accuracy for human toxicity.

Inventive Principle:
Principle #26Copying

Solution Approach 2:

The invention changes the physical and chemical parameters of the cell culture environment (continuous perfusion, controlled oxygen tension, nutrient supply) to extend cell viability and functional maintenance from days to months. This enables long-term toxicity assessment in human cell lines without requiring animal models.

Inventive Principle:
Principle #35Parameter changes

3Ease of manufacture

If fluorescence intensity measurements are used for oxygen sensing, then optical detection is achieved, but measurement reliability decreases due to focus changes and cell movement

Engineering Contradiction:
Improvedetection method simplicityVSAvoidmeasurement stability
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The invention changes the measurement parameter from fluorescence intensity (which is focus-dependent) to fluorescence lifetime (which is independent of focus and cell movement). Oxygen concentration is determined by measuring the decay time of the fluorescent probe's emission, providing reliable measurements even when cells move or focus changes occur during time-lapse imaging.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention replaces intensity-based optical detection with lifetime-based detection. This substitution uses the temporal characteristics of fluorescent emission decay rather than spatial intensity variations, making the measurement immune to focus drift and cell position changes while maintaining optical detection simplicity.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

4Measurement precision

If large numbers of cells are used for toxicity assays, then statistical significance is improved, but the number of cells required increases

Engineering Contradiction:
Improveassay reliabilityVSAvoidcell number
Core Design Contradiction:
Measurement precisionVSQuantity of substance

Solution Approach 1:

The invention enables continuous monitoring of the same cell population over extended periods (days to months) using time-lapse imaging of fluorescent probes. This longitudinal approach replaces the need for multiple parallel assays with large cell numbers, as the same cells provide repeated measurements that accumulate statistical significance over time rather than requiring large initial cell populations.

Inventive Principle:
Principle #20Continuity of useful action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables reliable, long-term, high-throughput monitoring of cellular viability and toxicity, reducing the need for end-point assays and minimizing cell numbers, while providing accurate toxicokinetic information and mimicking human physiology.

Implementation Method 1

oxygen sensing particles for non-invasive, real-time monitoring of oxygen uptake

Methodology Applied
Scientific EffectFluorescence quenching: Fluorescence

Data Source

PatentUS9657260B2Method and system for continous monitoring of toxicity
Publication Date: 2017.05.23 COLIBRI PHOTONICS
  • US9657260B2 patent drawing
  • US9657260B2 patent drawing
  • US9657260B2 patent drawing

AI summary

Systems, kits and methods for non-invasive, long-term, real-time monitoring of one or more physiological parameters of a cell, including but not limited to oxygen uptake, are provided.